Prevalence and risk factors associated with precancerous and cancerous cervical lesions among HIV-infected women in University of Gondar specialized comprehensive referral hospital, Northwest Ethiopia: cross-sectional study design
- PMID: 38834999
- PMCID: PMC11149268
- DOI: 10.1186/s12905-024-03174-0
Prevalence and risk factors associated with precancerous and cancerous cervical lesions among HIV-infected women in University of Gondar specialized comprehensive referral hospital, Northwest Ethiopia: cross-sectional study design
Abstract
Background: Cervical cancer is one of the leading causes of death in women worldwide. The majority of the cases are found in developing countries. The increasing risk of cervical cancer prevalence and growing danger of death from cervical cancer and the high occurrence of human papillomavirus (HPV) infection in women who are HIV positive give us the ground to study the prevalence and associated risk factors.
Objective: The study aims to assess the prevalence of cervical cancer screening and associated risk factors among HIV-positive women attending the Adult ART clinic at the University of Gondar Hospital.
Methods: An institution-based cross-sectional study was conducted from March to August 2021, on adult HIV-positive women attending the Adult ART clinic at Gondar University Referral Hospital by phone calling patients per week for six months to complete a total of 2744 HIV-positive patients who were not screened for cervical cancer before. The data were collected using an interviewer-administered questionnaire. Bivariate and multivariable logistic regression analyses were used to determine the presence and the degree of association between dependent and independent variables. In the multivariable logistic analysis, a P-value of < 0.05 and odds ratio with a 95% confidence interval were considered to determine independent predictors for the prevalence of premalignant or malignant cervical lesions among HIV-positive patients.
Result: This study assessed 915 HIV Positive women who were screened for cervical cancer via visual inspection with acetic acid (VIA) as the primary screening tool and found that 24.48% had positive VIA results. Those with VIA-positive cases pathology examination showed 72.4% had abnormal pathology reports (CIN 1/2/3-51.25%, 17.23% cancer & 3.9% CIS), strengthening the finding in many studies that suggest HIV-positive women have a high rate of premalignant lesions.
Keywords: Cancer; Cervix; HIV positive; Precancerous.
© 2024. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Low uptake of cervical cancer screening among HIV positive women in Gondar University referral hospital, Northwest Ethiopia: cross-sectional study design.BMC Womens Health. 2018 Jun 7;18(1):87. doi: 10.1186/s12905-018-0579-z. BMC Womens Health. 2018. PMID: 29879969 Free PMC article.
-
Histopathological profile of cervical punch biopsies and risk factors associated with high-grade cervical precancerous lesions and cancer in northwest Ethiopia.PLoS One. 2022 Sep 12;17(9):e0274466. doi: 10.1371/journal.pone.0274466. eCollection 2022. PLoS One. 2022. PMID: 36094938 Free PMC article.
-
Association between HIV Serostatus and premalignant cervical lesions among women attending a cervical cancer screening clinic at a tertiary care facility in southwestern Uganda: a comparative cross-sectional study.BMC Womens Health. 2024 Apr 27;24(1):266. doi: 10.1186/s12905-024-03108-w. BMC Womens Health. 2024. PMID: 38678278 Free PMC article.
-
HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer.AIDS. 2018 Mar 27;32(6):795-808. doi: 10.1097/QAD.0000000000001765. AIDS. 2018. PMID: 29369827 Free PMC article.
-
Precancerous cervical lesion and associated factors among HIV-infected women in Ethiopia: systematic review and meta- analysis.BMC Cancer. 2024 Jun 3;24(1):678. doi: 10.1186/s12885-024-12462-9. BMC Cancer. 2024. PMID: 38831404 Free PMC article.
Cited by
-
Human Papillomavirus and Other Relevant Issues in Cervical Cancer Pathogenesis.Int J Mol Sci. 2025 Jun 10;26(12):5549. doi: 10.3390/ijms26125549. Int J Mol Sci. 2025. PMID: 40565012 Free PMC article. Review.
References
-
- Bogani G, Sopracordevole F, Ciavattini A et al. November. Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV); The Investigators of the Italian HPV study group (iHPV study group). Duration of human papillomavirus persistence and its relationship with recurrent cervical dysplasia. European Journal of Cancer Prevention 2023;32(6):525–532. 10.1097/CEJ.0000000000000822. - PubMed
-
- Tullio D, Andrea G, Giorgio B. Prevention, Screening, Treatment and Follow-Up of gynecological cancers: state of art and future perspectives. Clin Exp Obstet Gynecol. 2023;50(8):160. doi: 10.31083/j.ceog5008160. - DOI
-
- Cancer IICoHa. Ethiopia. Human Papillomavirus and Related Cancers, Fact Sheet 2015.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical